Answers are grounded in this paper and cite their sources.
Research reveals the mechanism of action of a boron-dependent antibiotic, indicating its potential in drug development.
Laspartomycin C (LspC) is a calcium-dependent antibiotic (CDA), a family of peptide antibiotics that has an intriguing mechanism of action (MOA) and great promise in drug development.
No takes yet. Share an insight, caveat, or question.
Sh et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: